Observational studyBreast cancer (Tokyo, Japan)2021

Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.

Yutaka Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.